Quick summary
- Yes, checklists exist. Many are published and some are free online; a search for "GCP audit checklists" returns a wide range to adapt to your study and quality system.
- Build it in, don't bolt it on. USDM auditors recommend including a checklist in your quality assurance process — don't wait until you get an audit notice to prepare.
- Anchor it to the regulations. A useful checklist maps to ICH E6 and the applicable FDA clinical research regulations rather than to a generic template.
- Treat readiness as continuous. Inspection readiness is a maintained state, not a one-time scramble before a regulator arrives.
There are a number of GCP audit checklists and some of them are available for free online. An Internet search for "GCP audit checklists" will provide you with many to choose from. The auditors at USDM Life Sciences recommend including a checklist as part of your quality assurance process – don't wait until you get an audit notice to prepare.
A checklist is only as valuable as the discipline behind it. The strongest clinical quality programs treat a GCP audit checklist as a living instrument tied to Good Clinical Practice expectations, internal SOPs, and the specific risks of each study – not a form to complete once and file away. Used that way, it surfaces gaps while there is still time to fix them.
What Is a GCP Audit, and Why Does the Checklist Matter?
Good Clinical Practice (GCP) is the international quality standard for designing, conducting, recording, and reporting clinical trials that involve human subjects. It protects the rights, safety, and well-being of participants and gives regulators confidence that the resulting data are credible. A GCP audit is a systematic, independent examination of trial-related activities and documents to determine whether they were conducted, recorded, and reported in line with the protocol, the sponsor's SOPs, GCP, and applicable regulatory requirements.
A checklist matters because GCP touches so many moving parts – the protocol, informed consent, investigator oversight, source data, the trial master file, safety reporting, drug accountability, and the systems that store electronic records. Without a structured prompt, even experienced teams miss items under audit pressure. A well-built checklist turns institutional knowledge into a repeatable process applied consistently across studies, sites, and auditors.
Key principle: A checklist does not replace judgment. It ensures that nothing routine is overlooked, freeing your auditors to focus their judgment on the findings that actually carry risk. Pair it with disciplined data integrity practices so the records behind each checklist item can withstand scrutiny.
The Regulatory Foundations a GCP Checklist Should Reflect
A GCP audit checklist should not be generic; it should map to the regulatory framework that governs your trial. For studies conducted under or submitted to the U.S. Food and Drug Administration, and for trials following the international harmonized standard, the most commonly referenced sources include the following.
Core GCP regulatory references
- ICH E6, Good Clinical Practice: the internationally harmonized standard that defines the responsibilities of sponsors, investigators, and monitors, and the expectations for essential documents and the trial master file.
- 21 CFR Part 312: FDA regulations governing investigational new drug (IND) applications and the conduct of clinical investigations, including sponsor and investigator responsibilities.
- 21 CFR Part 50: protection of human subjects, including the requirements for informed consent.
- 21 CFR Part 56: Institutional Review Board (IRB) review and oversight of clinical research.
- 21 CFR Part 11: requirements for electronic records and electronic signatures, which apply to the computerized systems used to capture and manage trial data.
- 21 CFR Part 812: investigational device exemption (IDE) requirements for clinical studies of medical devices.
Mapping each checklist section to a specific regulation keeps the audit defensible and makes findings easier to communicate to study teams, who can see exactly which requirement a gap relates to. When computerized systems are in scope, the checklist should reach into 21 CFR Part 11 compliance – audit trails, access controls, and the validation status of the systems holding regulated records.
What a GCP Audit Checklist Typically Covers
The exact contents vary by trial phase, therapeutic area, and whether the audit is sponsor-, site-, or system-focused, but most GCP audit checklists organize their questions around a recognizable set of domains so every essential document and activity has a place to be checked.
Common GCP checklist domains
- Protocol and amendments: conduct per the approved protocol; amendments reviewed, approved, and implemented correctly.
- Informed consent: current, IRB-approved, versioned consent forms signed and dated before study procedures, with re-consents handled when required.
- IRB/IEC oversight: approvals, continuing reviews, and notifications documented and current.
- Investigator and site responsibilities: delegation logs, qualifications, training records, and adequate oversight of the trial.
- Source data and source documents: data that are attributable, legible, contemporaneous, original, and accurate, with case report forms reconciling to source.
- Trial master file and essential documents: required essential documents present, current, and filed throughout the trial.
- Safety reporting: adverse and serious adverse events captured, assessed, and reported within required timelines.
- Investigational product accountability: receipt, storage, dispensing, reconciliation, and return or destruction records.
- Computerized systems and records: validation status, audit trails, access controls, and data integrity for systems in scope.
The best moment to find a gap is during your own audit, when you still control the timeline. The worst moment is during a regulatory inspection, when you do not.
Internal Audits, Vendor Audits, and Inspection Readiness
A GCP audit checklist is rarely used in a single context. It supports routine internal quality audits, audits of clinical sites, and audits of the contract research organizations and technology vendors that support a trial. Because much of the clinical data ecosystem now runs on third-party platforms – electronic data capture, eTMF, randomization, and safety systems – a mature checklist also folds in third-party risk management questions about how vendors validate and maintain the systems that hold your regulated data.
Regulators conduct their own GCP inspections. In the United States, the FDA's Bioresearch Monitoring (BIMO) program inspects clinical investigators, sponsors, monitors, contract research organizations, and IRBs to verify the quality and integrity of clinical trial data and confirm that human subject protections were upheld. A checklist that mirrors the areas inspectors examine lets an organization rehearse before the real thing – which is why building it into routine quality assurance, rather than waiting for an audit notice, is so valuable.
Readiness is a maintained state. Organizations that treat inspection readiness as an ongoing discipline – supported by approaches such as continuous compliance for cloud systems – spend far less energy preparing for any individual audit, because the evidence is already organized, current, and defensible.
Choosing, Adapting, and Future-Proofing a Free Checklist
The free GCP audit checklists online are starting points, not finished tools. Before adopting one, confirm it maps to ICH E6 and the FDA regulations that apply to your trials, fits your study type and phase, ties each item to a specific requirement, and weights the highest-risk areas such as consent, safety reporting, and data integrity. As clinical teams adopt AI-enabled tools for data review, monitoring, and document management, the same diligence applies – folding AI governance and compliance into the conversation keeps newer technologies inside the same controlled, evidence-backed framework you apply to traditional systems.
Where USDM Fits In
USDM Life Sciences has a combination of over 100 years in regulatory compliance, Quality Assurance, Quality Systems and auditing. USDM's auditors in the Global Audits Practice Team perform audits on Pharmaceutical, Biotech, and Medical Device companies in the United States and abroad.
That breadth means USDM can help you do more than download a checklist. We help organizations build risk-based audit programs, conduct internal and vendor GCP audits, prepare for regulatory inspections, and establish quality systems that keep clinical research in a continuous state of readiness – so the checklist is one component of a defensible quality approach, not a substitute for one.
FAQ: GCP Audit Checklists
Is there a single official GCP audit checklist?
No. There is no one mandated checklist. Many GCP audit checklists are published, and some are available for free online; a search for "GCP audit checklists" returns many options. The right approach is to adapt a sound checklist to your study type, regulatory framework, and quality system rather than relying on a generic template.
When should we build a GCP checklist into our process?
Before you need it. The auditors at USDM recommend including a checklist as part of your quality assurance process so it supports routine internal audits and ongoing readiness – not waiting until you receive an audit or inspection notice to prepare.
Which regulations should a GCP checklist reference?
For FDA-regulated trials, a checklist commonly maps to ICH E6 (Good Clinical Practice) along with 21 CFR Part 312 (IND and clinical investigations), Part 50 (informed consent), Part 56 (IRBs), and Part 11 (electronic records and signatures). Device studies also reference 21 CFR Part 812 (investigational device exemptions).
How does a checklist help with regulatory inspections?
A checklist that mirrors the areas inspectors examine – such as those reviewed under the FDA's Bioresearch Monitoring (BIMO) program – lets an organization rehearse and find gaps internally while it still controls the timeline, instead of discovering them during an actual inspection.
Prepare Before the Audit Notice Arrives
A GCP audit checklist is most powerful when it is built into your quality assurance process and used continuously, not pulled out the week an audit is announced. If you want help turning a checklist into a defensible, risk-based audit and inspection-readiness program, contact USDM to talk through your clinical quality and GCP audit needs.